AR126078A1 - Compuestos de 2,8-diazaspiro[4.5]decano - Google Patents

Compuestos de 2,8-diazaspiro[4.5]decano

Info

Publication number
AR126078A1
AR126078A1 ARP220101483A ARP220101483A AR126078A1 AR 126078 A1 AR126078 A1 AR 126078A1 AR P220101483 A ARP220101483 A AR P220101483A AR P220101483 A ARP220101483 A AR P220101483A AR 126078 A1 AR126078 A1 AR 126078A1
Authority
AR
Argentina
Prior art keywords
compound
formula
diazaspiro
group
decane
Prior art date
Application number
ARP220101483A
Other languages
English (en)
Spanish (es)
Inventor
Steven John Mckerrall
Alice Rose Wong
James John Crawford
Wendy Lee
Kwong Wah Lai
Guillaume Pelletier
Stphanie Roy
Dana Krystin Winter
Mikiko Okumura
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AR126078A1 publication Critical patent/AR126078A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pens And Brushes (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
ARP220101483A 2021-06-04 2022-06-03 Compuestos de 2,8-diazaspiro[4.5]decano AR126078A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2021098358 2021-06-04

Publications (1)

Publication Number Publication Date
AR126078A1 true AR126078A1 (es) 2023-09-06

Family

ID=84322789

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220101483A AR126078A1 (es) 2021-06-04 2022-06-03 Compuestos de 2,8-diazaspiro[4.5]decano

Country Status (11)

Country Link
US (1) US20240174696A1 (https=)
EP (1) EP4347594A4 (https=)
JP (1) JP2024521929A (https=)
KR (1) KR20240016977A (https=)
CN (1) CN117425654A (https=)
AR (1) AR126078A1 (https=)
AU (1) AU2022284188A1 (https=)
BR (1) BR112023025393A2 (https=)
CA (1) CA3222054A1 (https=)
TW (1) TW202313608A (https=)
WO (1) WO2022253341A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101679418A (zh) * 2007-04-06 2010-03-24 诺瓦提斯公司 用作蛋白质激酶抑制剂的[2,6]萘啶类化合物
JP2011529932A (ja) * 2008-08-05 2011-12-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換ナフチリジン及び医薬としてのその使用
WO2012167423A1 (en) * 2011-06-08 2012-12-13 Hutchison Medipharma Limited Substituted pyridopyrazines as novel syk inhibitors
KR20140048216A (ko) * 2011-06-29 2014-04-23 오츠카 세이야쿠 가부시키가이샤 치료 화합물로서의 퀴나졸린 및 관련된 사용 방법
TWI675836B (zh) * 2014-03-25 2019-11-01 美商伊格尼塔公司 非典型蛋白質激酶ｃ之氮雜喹唑啉抑制劑
JOP20190257A1 (ar) * 2017-04-28 2019-10-28 Novartis Ag مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats
KR102328435B1 (ko) * 2018-09-11 2021-11-18 재단법인 대구경북첨단의료산업진흥재단 신규 피리도-피리미딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 단백질 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물
WO2021050059A1 (en) * 2019-09-11 2021-03-18 Provincial Health Services Authority Dna-pk inhibiting compounds

Also Published As

Publication number Publication date
CN117425654A (zh) 2024-01-19
TW202313608A (zh) 2023-04-01
AU2022284188A1 (en) 2023-11-30
WO2022253341A1 (en) 2022-12-08
EP4347594A1 (en) 2024-04-10
BR112023025393A2 (pt) 2024-02-27
KR20240016977A (ko) 2024-02-06
US20240174696A1 (en) 2024-05-30
JP2024521929A (ja) 2024-06-04
EP4347594A4 (en) 2025-06-18
CA3222054A1 (en) 2022-12-08

Similar Documents

Publication Publication Date Title
AR075243A1 (es) Derivados del 1-fenil-2-piridinil alquil alcohol como inhibidores de fosfodiesterasa
CO6150151A2 (es) Espirociclos como inhibidores de la 11-beta hidroxiesteroide deshidrogenasa de tipo 1
TNSN07397A1 (en) Acetylene derivatives
PE20130376A1 (es) [1,8]naftiridinas sustituidas por 2,4-diarilo como inhibidores de quinasas para uso contra el cancer
AR086357A1 (es) Derivados de indazol sustituidos activos como inhibidores de quinasas
AR087328A1 (es) Derivados de imidazo[1,2-b]piridazina e imidazo[4,5-b]piridina como inhibidores de jak
CO5640104A2 (es) Derivados de aminoisoxazol activos como inhibidores de quinasa
ES8400400A1 (es) "un metodo de producir derivados de 1-sulfo-2-oxoazetidina".
AR029301A1 (es) Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos
RU2012104700A (ru) Азабициклосоединение и его соль
AR007253A1 (es) Derivados de pirimidina o sus sales y n-oxidos farmaceuticamente aceptables composicion farmaceutica que los contiene, procedimiento para preparar a dichosderivados y metodo para la preparacion de una composicion farmaceutica conteniendo a uno de dichos derivados
AR092253A1 (es) Inhibidores de serina/treonina cinasa
AR053120A1 (es) Aminopiridinas como inhibidores de beta secretasa
MX2012002973A (es) Derivados de pirimidona herbicidas.
ES2600636T3 (es) Spiro-[1,3]-oxazinas y spiro-[1,4]-oxazepinas como inhibidores de BACE1 y/o BACE2
ES8609236A1 (es) Un metodo para preparar derivados de 1-sulfo-2-oxoazetidina
EA200500268A1 (ru) Производные диоксан-2-алкилкарбаматов, способ их получения и применение в терапии
EA200100994A1 (ru) 1-АМИНОТРИАЗОЛО[4,3-а]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ-IV
AR036176A1 (es) Un derivado de fenil-acetamido-tiazol, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un producto o kit que los comprende, y un metodo que utiliza dicho derivado
AR089853A1 (es) Inhibidores de oxadiazol de la produccion de leucotrienos para terapia de combinacion, composicion farmaceutica, uso
AR057063A1 (es) Moduladores de tienopirimidina y tienopiridina quinasa y composicion farmaceutica
AR047531A1 (es) Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa
AR126078A1 (es) Compuestos de 2,8-diazaspiro[4.5]decano
AR051373A1 (es) Procedimiento para la preparacion de analogos aciclicos de nucleotidos de fosfonatos
AR072880A1 (es) Derivados nitrogenados de la pancratistatina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal